Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant
Clinical trial NCT01106027 · TERMINATED
Trial details
- NCT number
- NCT01106027
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2016-08-19
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.